Get startedLog in
    Picture of Dare Bioscience logo

    DARE — Dare Bioscience News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Daré Bioscience Announces Additional Positive Data From Exploratory Phase 2B Respond Study Of Sildenafil Cream

    Picture of Dare Bioscience logoDare Bioscience
    11/07/2023 13:56
    July 11 (Reuters) - Daré Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES ADDITIONAL POSITIVE DATA FROM
EXPLORATORY PHASE 2B RESPOND STUDY OF SILDENAFIL CREAM, 3.6% IN
WOMEN

Source text for Eikon:  ID:nGNX4CTj0N 
Further company coverage:  DARE.O 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Dare Bioscience

    See all news